Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device
Launched by CENTRE HOSPITALIER DE SAINT-DENIS · Jun 26, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new device called DARE that can measure blood pressure without the need for tubes or needles inside the body. It is designed for patients in the intensive care unit (ICU), where close monitoring of blood pressure and other vital signs like body temperature, oxygen levels, and heart rhythm is very important. The study compares the DARE device’s readings to the usual invasive methods, which involve inserting tubes into blood vessels and the body. The goal is to see if the DARE device can provide accurate, comfortable, and safer monitoring for very sick patients.
Adults 18 years and older who are staying in the ICU for more than two days and already have invasive monitors for blood pressure and temperature may be eligible to join. People with certain skin allergies, active implanted devices like pacemakers, or those who cannot give informed consent are not eligible. Participants will wear the DARE device while receiving their usual care, and doctors will compare the results. This study hopes to make it easier and safer for patients to be closely watched during critical illness.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (male or female), aged 18 years or older
- • Admitted to intensive care unit (ICU) or critical care with an expected hospital stay longer than 2 days
- • Equipped with an arterial catheter for invasive blood pressure monitoring
- • Equipped with a urinary catheter for invasive core body temperature monitoring
- Exclusion Criteria:
- • Patients under 18 years old (minors)
- • Known skin allergy to adhesives or silicone, or skin condition preventing adhesive use
- • History of extensive skin pathology (e.g., Lyell syndrome)
- • Patients with therapeutic limitations
- • Patients with active implanted medical devices (e.g., pacemaker, defibrillator)
- • Pregnant or breastfeeding women
- • Patients not affiliated with the French social security system
- • Patients or their legal representatives refusing consent, or unable to understand information and give informed consent
- • Patients under legal guardianship, curatorship, or deprived of liberty
About Centre Hospitalier De Saint Denis
The Centre Hospitalier de Saint-Denis is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. Located in Saint-Denis, France, the hospital is renowned for its commitment to patient-centered care, innovative treatments, and interdisciplinary collaboration. As a clinical trial sponsor, it actively engages in the development of new therapeutic options, striving to enhance patient outcomes through rigorous research protocols and adherence to ethical standards. With a focus on diverse medical disciplines, the Centre Hospitalier de Saint-Denis plays a pivotal role in contributing to the advancement of medical knowledge and the improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Denis, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported